RESOLUTION OF THE PRESIDENT OF THE REPUBLIC OF UZBEKISTAN

of January 28, 2020 No. PP-4574

About creation of innovative research and production pharmaceutical cluster of "Tashkent Pharma Park"

For the purpose of production organization of innovative and high-quality medicines, products of medical appointment and medical equipment, satisfaction of demand of the population for the specified goods, ensuring training of specialists of pharmaceutical industry on the basis of the international educational standards and on demanded specialties, consecutive integration of pharmaceutical education into system of the international scientific community, and also further development of pharmaceutical industry in the republic:

1. Accept the offer of the Ministry of investments and foreign trade, the Ministry of Health, Ministry of Economy and Industry, Ministry of the higher and secondary vocational education of the Republic of Uzbekistan, khokimiyat of the Tashkent region on creation in Zangiatinsky district of the Tashkent region of innovative research and production pharmaceutical cluster of "Tashkent Pharma Park" (further - the Cluster).

2. Determine that the Cluster includes creation:

a) Pharmaceutical technical university (further - University) with own infrastructure consisting from:

research centers and laboratories;

educational and scientific laboratories and vivarium;

pharmacopoeian center;

symposium center with hotel;

the places of residence for students, teachers and foreign employees;

sports complex, pool and stadium;

b) the industrial zone consisting of floor spaces on release of innovative medicines, products of medical appointment and medical equipment (further - the industrial zone).

3. Determine the main objectives and activities:

a) Cluster:

development of pharmaceutical industry of the republic by implementation of innovative solutions (know-how) and high technologies using the international experience;

creation of specialized educational infrastructure for training of qualified personnel according to the international training programs on the specialties demanded in pharmaceutical industry;

development of research base by its integration into the international innovative system, creations modern educational and laboratory and research centers, and also innovative infrastructure;

investment attraction and advanced technologies, including the foreign pharmaceutical companies, for creation of modern competitive productions on release of innovative and high-quality medicines, products of medical appointment and medical equipment;

providing conditions for participation of the scientific and educational and research centers in scientific and technical and innovative programs, tenders and grants;

adjustment of cooperation with similar foreign research centers by the organization of permanent experience exchange and data, ensuring practical participation in the international research programs, conferences and symposiums;

b) University:

training of qualified personnel in the field of production of medicines, products of medical appointment and medical equipment, cosmetology, management of industry and business according to the international educational standards;

implementation of the innovative and effective educational programs and forms of education directed to enhancement and upgrade of system of training in pharmaceutical industry;

implementation of retraining and advanced training of specialists and research and educational personnel at the expense of continuity and succession of science and education, and also their integration into world educational and scientific community;

creation of conditions for close integration of pharmaceutical education, science and production;

carrying out basic and applied scientific research in the field of pharmacy, biotechnologies, biopharmacy, development and use of medicines, products of medical appointment and medical equipment for pharmaceutical industry;

development and strengthening of the long-term relations with the lead educational institutions, research centers and business community of foreign countries.

Take into consideration that the preliminary agreement on creation of University with own infrastructure due to attraction of long-term soft credits of the Government of the Republic of Korea through Fund of economic cooperation and development (EDCF) is reached.

4. Approve:

The concept of creation of innovative research and production pharmaceutical cluster of "Tashkent Pharma Park" according to appendix No. 1;

The plan of practical actions for creation of innovative research and production pharmaceutical cluster of "Tashkent Pharma Park" according to appendix No. 2;

The development program of transport, engineering and communication and production infrastructure in the territory of innovative research and production pharmaceutical cluster of "Tashkent Pharma Park" according to appendix No. 4.

5. Form:

Disclaimer! This text was translated by AI translator and is not a valid juridical document. No warranty. No claim. More info